New 5-Modified Pyrimidine Nucleoside Inhibitors of Mycobacterial Growth

Обложка

Цитировать

Полный текст

Аннотация

The WHO has declared tuberculosis (TB) a global health emergency. Therefore, there is an urgent need to discover and develop new anti-TB drugs. Here we report a new category of 5-substituted pyrimidine nucleosides as potent inhibitors of Mycobacterium tuberculosis growth in vitro. A series of 2'-deoxy-, 3'-azido-2',3'-dideoxy-, and 3'-amino-2',3'-dideoxypyrimidine nucleoside analogues bearing lengthy flexible alkyloxymethyl substituents exhibited marked inhibitory activity against M tuberculosis in vitro. 5-Dodecyloxymethyl-2'-deoxyuridine was found to be a potent inhibitor of M. tuberculosis propagation in vitro. In contrast, monophosphates of the tested nucleosides were devoid of antimycobacterial activity. This new class of inhibitors seems to be a promising chemotherapeutic agent against TB and merits further studies.

Полный текст

New 5-Modified Pyrimidine Nucleoside Inhibitors of Mycobacterial Growth
×

Об авторах

L A Alexandrova

Email: ala200407@mail.ru

E R Shmalenyuk

S N Kochetkov

V V Erokhin

T G Smirnova

S N Andreevskaia

L N Chernousova

Список литературы

  1. Word Health Org., http://www/who/int/mediacentre/fastsheets/fs104/en/.2005
  2. Banerjee R., Schecter G.F., Flood J., Porco T.C. // Expert Rev Anti Infect Ther. 2008. V. 6. P. 713-724.
  3. Bucher H.C., Griffith L.E., Guyatt G.H., et al // AIDS 1999, V. 13. P. 501-507.
  4. Daley C.L., Small P.M., Schecter G.F., et al // N. Engl. J. Med. 1992. V. 326. P. 231-235.
  5. Ginsberg A.M., Spigelman M. // Nat Med. 2007. V. 13. P. 290-294.
  6. Tsuyuguchi I. // Tuberculosis (Edinb). 2001. V. 81. P. 221-227.
  7. Tuberculosis in Russia. “Prima” Moscow, 2009
  8. De Clercq E. // Adv Virus Res. 2009. V. 73. P. 1-53.
  9. Van Calenbergh S. // Verh K Acad Geneeskd Belg. 2006. V. 68. P. 223-248.
  10. Gupte A., Boshoff H.I., Wilson D.J., et al // J. Med. Chem. 2008, V. 51, P. 7495-7507
  11. Rai D., Johar M., Manning T., et al // J. Med. Chem. 2005, V. 48, P. 7012-7017.
  12. Rai D., Johar M., Srivastav N.C., et al // J. Med. Chem. 2007, V. 50, P. 4766-4774
  13. Johar M., Manning T., Tse C., et al // J. Med. Chem. 2007, V. 50, H. 3696-3705.
  14. Srivastav N.C., Manning T., Kunimoto D.Y., Kumar R. // Bioorganic & Medical Chemistry, 2007, V. 15, P. 2045-2053
  15. Alexandrova L.A., Skoblov A.Yu., Jasko M.V., Victorova L.S., Krayevsky A.A. // Nucl. Acids Res., 1998, V. 26, P. 778-786.
  16. Dyatkina N.B., von Janta-Lipinski M., Minasyan Sh.H., et al // Bioorg. Khim., 1987. V. 13. P. 1366-1374.
  17. Andreevskaia S.N., Chernousova L.N., Smirnova T.G., Larionova E.E., Kuz’min A.V. // Probl Tuberk Bolezn Legk. 2006;(12): 43-48.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© Alexandrova L.A., Shmalenyuk E.R., Kochetkov S.N., Erokhin V.V., Smirnova T.G., Andreevskaia S.N., Chernousova L.N., 2010

Creative Commons License
Эта статья доступна по лицензии Creative Commons Attribution 4.0 International License.

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах